Agenda
Thursday, May 14, 2020
Nirali N. Shah, Pediatric Oncology Branch, NCI
Current State of the Art in CAR T-cell Neurotoxicity
Speaker: Haneen Shalabi, Pediatric Oncology Branch, NCI
Neuroimaging in CAR T-cell Therapy
Speaker: Agne Taraseviciute, Pediatric Hematology/Oncology, CHLA
Neurocognitive Evaluations
Speaker: Pam Wolters, Pediatric Oncology Branch, NCI
Establishing Comprehensive and Uniform Biologic Correlatives
Speaker: Juliane Gust, Pediatric Neurology, Seattle Children’s
The Patient/Parent Experience with CAR T-cells
Speaker: Carlos Sandi, Patient/Parent Advocate
Patient Reported Quality of Life after Tisagenlecleucel
Speaker: Ted Laetsch, Pediatrics Hematology/Oncology, UT Southwestern
PROs: What should be used for CAR T-cells
Speaker: Allison Leahy, Pediatric Hematology/Oncology, CHOP
Comprehensive Care Model
Speaker: Lori Wiener, Pediatric Oncology Branch, NCI
Infections and CAR T-cells
Speaker: Veronique Nussenblatt, Infectious Disease, NIAID, NIH
Immune Reconstitution and Vaccine Strategies Post CAR
Speaker: Josh Hill, Allergy and Infectious Diseases, Fred Hutch Cancer Research Center
Optimizing Treatment of Extramedullary Disease
Speaker: Kevin Curran, Pediatric Hematology/Oncology, MSKCC
Hematologic Toxicities
Speaker: Tim Olson, Pediatric BMT, CHOP
Hemophagocytic Lymphohistiocytosis
Speaker: Nirali N. Shah, Pediatric Oncology Branch, NCI
How to Evaluate a New Malignancy Post CAR
Speakers: Hao-Wei Wang, Hematopathology, NCI & Javed Khan, Genetics Branch, NCI
Prevention of Early Failure of CAR T-cells
Speaker: Steve Grupp, Pediatric Hematology/Oncology, CHOP
Management of CAR T-cell Relapse
Speaker: Colleen Annesley, Pediatric Hematology/Oncology, Seattle Children’s
Role for Consolidative HSCT
Speaker: Mike Pulsipher, Pediatric Hematology/Oncology, CHLA
Transplant Late Effects Study
Speaker: Christine Duncan, Pediatric BMT, Children’s Hospital Boston
Collaborating with CIBMTR
Speaker: Marcelo Pasquini, CIBMTR
Real-World Kymriah
Speaker: Liora Schultz, Pediatric Hematology/Oncology, Stanford
Action Items and Future Directions
Speaker: Nirali N. Shah, Pediatric Oncology Branch, NCI